Does resection after neoadjuvant chemotherapy of docetaxel, oxaliplatin, and S-1 (DOS regimen) benefit for gastric cancer patients with single non-curable factor? a multicenter, prospective cohort study (Neo-REGATTA)
2023 · BMC Cancer · 12 citations
https://doi.org/10.1186/s12885-023-10773-x